The role of inflammasomes in human diseases and their potential as therapeutic targets

Jing Yao,Keenan Sterling,Zhe Wang,Yun Zhang,Weihong Song

DOI: https://doi.org/10.1038/s41392-023-01687-y

IF: 39.3

2024-01-06

Signal Transduction and Targeted Therapy

Abstract:Inflammasomes are large protein complexes that play a major role in sensing inflammatory signals and triggering the innate immune response. Each inflammasome complex has three major components: an upstream sensor molecule that is connected to a downstream effector protein such as caspase-1 through the adapter protein ASC. Inflammasome formation typically occurs in response to infectious agents or cellular damage. The active inflammasome then triggers caspase-1 activation, followed by the secretion of pro-inflammatory cytokines and pyroptotic cell death. Aberrant inflammasome activation and activity contribute to the development of diabetes, cancer, and several cardiovascular and neurodegenerative disorders. As a result, recent research has increasingly focused on investigating the mechanisms that regulate inflammasome assembly and activation, as well as the potential of targeting inflammasomes to treat various diseases. Multiple clinical trials are currently underway to evaluate the therapeutic potential of several distinct inflammasome-targeting therapies. Therefore, understanding how different inflammasomes contribute to disease pathology may have significant implications for developing novel therapeutic strategies. In this article, we provide a summary of the biological and pathological roles of inflammasomes in health and disease. We also highlight key evidence that suggests targeting inflammasomes could be a novel strategy for developing new disease-modifying therapies that may be effective in several conditions.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the role of inflammasomes in human diseases and their potential as therapeutic targets. Specifically, the paper summarizes the biological and pathological roles of different inflammasomes in both healthy and diseased states, and emphasizes that targeting inflammasomes could become a new strategy for developing novel disease-modifying therapies. The study finds that abnormal inflammasome activation is associated with the development of various diseases, including metabolic diseases, neurodegenerative diseases, and inflammatory diseases. Therefore, understanding how different inflammasomes lead to pathological changes in diseases is of great significance for developing new therapeutic approaches. Currently, several clinical trials are evaluating the efficacy of therapies targeting inflammasomes.